Abstract
The COVID-19 global pandemic has plagued the world and crippled many economies, taking millions of lives. With the emergence of newer and more potent variants of this virus, it is imperative to remain up to date with novel treatment modalities. Medical therapeutics has been the mainstay treatment and preventive measures used by most nations to prevent widespread disease. With the discovery of oral therapeutics that can reduce the potency of the COVID-19 infection, it is important that we tackle another global health issue – inequitable distribution of healthcare resources. This article aims to address the ethical concerns of allocation of scarce drugs, and a tiered approach to prevent misuse of such oral therapeutics. Scarce resources must be protected and distributed based on a needs basis, to improve healthcare worldwide and alleviate suffering from this pandemic.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
